Скачать с ютуб Webinar: Market access and patient delivery in advanced therapies в хорошем качестве

Webinar: Market access and patient delivery in advanced therapies

This webinar was the third webinar in our 'Understanding advanced and genetic therapies' webinar series. When it comes to advanced therapies, completing your clinical trial is really only the first step to patient benefit. Securing access for patients can be hugely challenging: Firstly, regulatory approval rightly requires exceptional safety data, as complications in genetic medicine can and have been severe. Secondly, with many advanced therapies being potentially curative, and single dose, prices are often exceptionally high and lead to a very challenging route to reimbursement from healthcare providers. Thirdly, with the production, transport, delivery and care associated with many advanced therapies being so complex and specialised, delivering the drug to the patient is often a significant challenge necessitating highly specialised facilities. A successful therapy must overcome all of these hurdles to deliver its benefit to those that need it. Watch Session 3 now to learn more about navigating these challenges and discover the importance of a well-planned programme for patient delivery for maximum impact. Learn: - The steps and processes involved in getting a gene therapy to market - The steps and processes involved in getting a gene therapy reimbursed - A case study showing how these challenges can be overcome - The challenges encountered when trying to deliver an approved and reimbursed gene therapy product to the patient community